Five new human cancer-germline genes identified among 12 genes expressed in spermatogonia

International Journal of Cancer

Volumn 105, Issue 3, 2003, Pages 371-376

  Loriot, Axelle ^a   Boon, Thierry ^a   De Smet, Charles ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

5 aza 2 deoxycytidine; Cancer germline genes; Cancer testis genes; DNA methylation; MAGE; Spermatogonia

Indexed keywords

ARTICLE; CONTROLLED STUDY; FTHL17 GENE; GENE; GENE EXPRESSION REGULATION; GENE ISOLATION; GERM LINE; HUMAN; HUMAN CELL; MALE; NUCLEOTIDE SEQUENCE; NXF2 GENE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPERMATOGONIUM; TAF2Q GENE; TDRD1 GENE; TEX15 GENE;

ANIMALS; AZACITIDINE; DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICE; NEOPLASMS; PROMOTER REGIONS (GENETICS); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPERMATOGONIA; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; X CHROMOSOME;

EID: 0038219825     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.11104     Document Type: Article

References (36)

1. Marchand M, van Baren N, Weynants P, Brichard V, Dréno B, Tessier M-H, Rankin E, Parmiani G, Arienti F, Humblet Y, Bourlond A, Vanwijck R, et al. Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1. Int J Cancer 1999;80:219-30.
2. Van den Eynde B, van der Bruggen P. T cell-defined tumor antigens. Curr Opin Immunol 1997;9:684-93.
3. De Smet C, Lurquin C, Lethé B, Martelange V, Boon T. DNA methylation is the primary silencing mechanism for a set of germ line-and tumor-specific genes with a CpG-rich promoter. Mol Cell Biol 1999;19:7327-35.
4. Old L. Cancer/testis (CT) antigens - a new link between gametogenesis and cancer. Cancer Immun 2001;1:1.
5. Coulie PG, Karanikas V, Lurquin C, Colau D, Connerotte T, Hanagiri T, Van Pel A, Lucas S, Godelaine D, Lonchay C, Marchand M, Van Baren N, et al. Cytolytic T-cell responses of cancer patients vaccinated with a MAGE antigen. Immunol Rev 2002;188:33-42.
6. Jassim A, Ollier W, Payne A, Biro A, Oliver RTD, Festenstein H. Analysis of HLA antigens on germ cells in human semen. Eur J Immunol 1989;19:1215-20.
7. Gure AO, Türeci Ö, Sahin U, Tsang S, Scanlan MJ, Jäger E, Knuth A, Pfreundschuh M, Old LJ, Chen Y-T. SSX: a multigene family with several members transcribed in normal testis and human cancer. Int J Cancer 1997;72:965-71.
8. De Smet C, Martelange V, Lucas S, Brasseur F, Lurquin C, Boon T. Identification of human testis-specific transcripts and analysis of their expression in tumor cells. Biochem Biophys Res Commun 1997;241:653-7.
9. Lucas S, De Smet C, Arden KC, Viars CS, Lethé B, Lurquin C, Boon T. Identification of a new MAGE gene with tumor-specific expression by representational difference analysis. Cancer Res 1998;58:743-52.
10. Takahashi K, Shichijo S, Noguchi M, Hirohata M, Itoh K. Identification of MAGE-1 and MAGE-4 proteins in spermatogonia and primary spermatocytes of testis. Cancer Res 1995;55:3478-82.
11. Cheville JC, Roche PC. MAGE-1 and MAGE-3 tumor rejection antigens in human germ cell tumors. Mod Pathol 1999;12:974-8.
12. Jungbluth A, Chen Y, Stockert E, Busam K, Kolb D, Iversen K, Coplan K, Williamson B, Altorki N, Old L. Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues. Int J Cancer 2001;92:856-60. Int J Cancer 2002;97:878.
13. Jungbluth A, Chen Y, Stockert E, Busam K, Kolb D, Iversen K, Coplan K, Williamson B, Altorki N, Old L. Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues. Int J Cancer 2001;92:856-60. Int J Cancer 2002;97:878.
14. dos Santos NR, Torensma R, de Vries TJ, Schreurs MW, de Bruijn DR, Kater-Baats E, Ruiter DJ, Adema GJ, van Muijen GN, van Kessel AG. Heterogeneous expression of the SSX cancer/testis antigens in human melanoma lesions and cell lines. Cancer Res 2000;60:1654-62.
15. Dudley K, Potter J, Lyon MF, Willison KR. Analysis of male sterile mutations in the mouse using haploid stage expressed cDNA probes. Nucleic Acids Res 1984;12:4281-93.
16. Skakkebaek NE, Heller CG. Quantification of human seminiferous epithelium. I. Histological studies in twenty-one fertile men with normal chromosome complements. J Reprod Fertil 1973;32:379-89.
17. Wang PJ, McCarrey JR, Yang F, Page DC. An abundance of X-linked genes expressed in spermatogonia. Nat Genet 2001;27:422-6.
18. Davis LG, Dibner MD, Battey JF. Guanidine isothiocyanate preparation of total RNA. In: Basic methods in molecular biology. New York: Elsevier, 1986. 130-5.
19. Weynants P, Lethé B, Brasseur F, Marchand M, Boon T. Expression of MAGE genes by non-small-cell lung carcinomas. Int J Cancer 1994;56:826-9.
20. De Smet C, Lurquin C, van der Bruggen P, De Plaen E, Brasseur F, Boon T. Sequence and expression pattern of the human MAGE2 gene. Immunogenetics 1994:39:121-9.
21. De Smet C, De Backer O, Faraoni I, Lurquin C, Brasseur F, Boon T. The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation. Proc Natl Acad Sci USA 1996;93:7149-53.
22. Lethé B, van der Bruggen P, Brasseur F, Boon T. MAGE-1 expression threshold for the lysis of melanoma cell lines by a specific CTL. Melanoma Res 1997;7:S83-8.
23. Serrano A, Lethé B, Delroisse J-M, Lurquin C, De Plaen E, Brasseur F, Rimoldi D, Boon T. Quantitative evaluation of the expression of MAGE genes in tumors by limiting dilution of cDNA libraries. Int J Cancer 1999;83:664-9.
24. Diala ES, Cheah MSC, Rotwich D, Hoffman RM. Extent of methylation in human tumor cells. J Natl Cancer Inst 1983;71:755-64.
25. Gama-Sosa MA, Slagel VA, Trewyn RW, Oxenhandler R, Kuo KC, Gehrke CW, Ehrlich M. The 5-methylcytosine content of DNA from human tumors. Nucleic Acids Res 1983;11:6883-94.
26. Weber J, Salgaller M, Samid D, Johnson B, Herlyn M, Lassam N, Treisman J, Rosenberg SA. Expression of the MAGE1 tumor antigen is upregulated by the demethylating agent 5-aza-2′-deoxycytidine. Cancer Res 1994;54:1766-71.
27. De Backer O, Arden KC, Boretti M, Vantomme V, De Smet C, Czekay S, Viars CS, De Plaen E, Brasseur F, Chomez P, Van den Eynde B, Boon T, et al. Characterization of the GAGE genes that are expressed in various human cancers and in normal testis. Cancer Res 1999;59:3157-65.
28. Lee L, Wang RF, Wang X, Mixon A, Johnson BE, Rosenberg SA, Schrump DS. NY-ESO-1 may be a potential target for lung cancer immunotherapy. Cancer J Sci Am 1999;5:20-5.
29. Liang G, Gonzales FA, Jones PA, Orntoft TF, Thykjaer T. Analysis of gene induction in human fibroblasts and bladder cancer cells exposed to the methylation inhibitor 5-aza-2′-deoxycytidine. Cancer Res 2002;62:961-6.
30. Brasseur F, Rimoldi D, Liénard D, Lethé B, Carrel S, Arienti F, Suter L, Vanwijck R, Bourlond A, Humblet Y, Vacca A, Conese M, et al. Expression of MAGE genes in primary and metastatic cutaneous melanoma. Int J Cancer 1995;63:375-80.
31. Scanlan MJ, Altorki NK, Gure AO, Williamson B, Jungbluth A, Chen YT, Old LJ. Expression of cancer-testis antigens in lung cancer: definition of bromodomain testis-specific gene (BRDT) as a new CT gene, CT9. Cancer Lett 2000;150:155-64.
32. Rice WR. Sex-chromosome and the evolution of sexual dimorphism. Evolution 1984:38:735-42.
33. Hurst LD, Randerson JP. An exceptional chromosome. Trends Genet 1999;15:383-5.
34. Jones MH, Zhang Y, Tirosvoutis KN, Davey PM, Webster AR, Walsh D, Spurr NK, Affara NA. Chromosomal assignment of 311 sequences transcribed in human adult testis. Genomics 1997;40:155-67.
35. Singer-Sam J, Robinson MO, Bellve AR, Simon MI, Riggs AD. Measurement by quantitative PCR of changes in HPRT, PGK-1, PGK-2, APRT, MTase, and Zfy gene transcripts during mouse spermatogenesis. Nucleic Acids Res 1990;18:1255-9.
36. McCarrey JR, Dilworth DD, Sharp RM. Semiquantitative analysis of X-linked gene expression during spermatogenesis in the mouse: ethidium-bromide staining of RT-PCR products. Genet Anal Tech Appl 1992;9:117-23.